<code id='5224069276'></code><style id='5224069276'></style>
    • <acronym id='5224069276'></acronym>
      <center id='5224069276'><center id='5224069276'><tfoot id='5224069276'></tfoot></center><abbr id='5224069276'><dir id='5224069276'><tfoot id='5224069276'></tfoot><noframes id='5224069276'>

    • <optgroup id='5224069276'><strike id='5224069276'><sup id='5224069276'></sup></strike><code id='5224069276'></code></optgroup>
        1. <b id='5224069276'><label id='5224069276'><select id='5224069276'><dt id='5224069276'><span id='5224069276'></span></dt></select></label></b><u id='5224069276'></u>
          <i id='5224069276'><strike id='5224069276'><tt id='5224069276'><pre id='5224069276'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:16
          Silhouette of a medical staff, followed by another, running pushing a nursing bed. Two people talk next to the hurrying staff in the corridor — coverage from STAT
          Adobe

          There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too.

          Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nursing homes, hospice care, and physician practices.

          advertisement

          Even after adjusting their findings to be more conservative, the researchers on the JAMA study found that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. Not all of the increases were statistically significant.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          With Wegovy coverage, Medicare patients may face high costs
          With Wegovy coverage, Medicare patients may face high costs

          ApersonholdsaWegovyinjectionpen.KayanaSzymczakforSTATMedicareconfirmedthisweekthatitwillcoverNovoNor

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          In utero gene editing: an explainer

          AnnaYeo/STATRecentlyapprovedgenetherapiesofferpatientsone-time,potentiallycurativetreatmentsforgenet